Keppra, Levetiracetam News

My 21-year-old niece has a new compulsion to bite and chew things that might be due to her new epilepsy medication .

Main Category: Epilepsy Also Included In: Pediatrics / Children's Health ; Regulatory Affairs / Drug Approvals Article Date: 27 Jan 2012 - 9:00 PST In the U.S., Keppra has been approved as adjunctive therapy for partial onset seizures in adults and children aged four years and older with epilepsy .

UCB S.A AllA©e de la Recherche 60 1070 Brussels BELGIUM Tel.: +32 2 559 9999 Fax: +32 2 559 9900 E-mail: investor-relations@ucb.com 2012-01-25 UCB announces FDA approval for Keppra in infants and children from one month of age with partial onset seizures a FDA expands indication for Keppra as adjunctive therapy for partial onset seizures to ... (more)

Below are company-related news and stories from French and Benelux media which could have an impact on the region's markets or individual stocks.

Otsuka Pharmaceutical Co. Ltd, a wholly owned direct subsidiary of Otsuka Holdings Co.